Core-shell insulin-loaded nanofibrous scaffolds for repairing diabetic wounds

Nanomedicine. 2020 Feb:24:102123. doi: 10.1016/j.nano.2019.102123. Epub 2019 Nov 8.

Abstract

Patients with diabetes mellitus have up to a 15% lifetime risk of non-healing and poorly healing wounds. This work develops core-shell nanofibrous bioactive insulin-loaded poly-D-L-lactide-glycolide (PLGA) scaffolds that release insulin in a sustained manner for repairing wounds in diabetic rats. To prepare the biodegradable core-shell nanofibers, PLGA and insulin solutions were fed into two capillary tubes of different sizes that were coaxially electrospun using two independent pumps. The scaffolds sustainably released insulin for four weeks. The hydrophilicity and water-containing capacity of core-shell nanofibrous insulin/PLGA scaffolds significantly exceeded those of blended nanofibrous scaffolds. The nanofibrous core-shell insulin-loaded scaffold reduced the amount of type I collagen in vitro, increased the transforming growth factor-beta content in vivo, and promoted diabetic would repair. The core-shell insulin-loaded nanofibrous scaffolds prolong the release of insulin and promote diabetic wound healing.

Keywords: Coaxial electrospinning; Core-shell nanofiber; Diabetic wound; Insulin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bandages*
  • Delayed-Action Preparations / chemistry
  • Delayed-Action Preparations / pharmacokinetics
  • Delayed-Action Preparations / pharmacology
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / metabolism
  • Diabetes Mellitus, Experimental / pathology
  • Diabetic Angiopathies / drug therapy*
  • Diabetic Angiopathies / metabolism
  • Diabetic Angiopathies / pathology
  • Insulin* / chemistry
  • Insulin* / pharmacokinetics
  • Insulin* / pharmacology
  • Nanofibers* / chemistry
  • Nanofibers* / therapeutic use
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Delayed-Action Preparations
  • Insulin